Clinical trial

Exploring Barriers and Facilitators to Uptake of the MMR Vaccine Among Healthcare Workers at King's College Hospital NHS Foundation Trust

Name
344919
Description
Measles is a highly contagious disease which can result in severe complications in some patients. Healthcare workers have a higher risk of getting measles than the general population because of their increased risk of exposure from patients with measles attending hospitals. Having had measles in the past or at least one dose of the measles, mumps and rubella (MMR) vaccine provides protection (immunity) against measles. UK government guidelines therefore recommend that healthcare workers and non-clinical staff with direct patient contact are fully vaccinated or have other evidence of immunity. Yet, evidence from recent measles outbreaks suggests that some healthcare workers are not immune or do not know if they are immune, with implications for containment efforts, cost and transmission. The purpose of this study is to identify barriers and facilitators to uptake of the MMR vaccine among healthcare workers at King's College Hospital NHS Foundation Trust (KCH). KCH healthcare workers will be eligible to take part in the study if they are aged 18 and over and have direct contact with patients. In addition, the research will focus on four subgroups of healthcare workers at KCH: those who are not immune, those who have not completed the full vaccination schedule, those who don't know their immunity status, those received the vaccine only after joining KCH. The latter may provide insights into facilitators to vaccine uptake. Measles immunity forms part of the occupational health screening at KCH. A series of semi structured interviews lasting approximately 1 hour will explore participants' experiences of the occupational health vaccine screening process and measles vaccine campaigns at KCH; why they are unvaccinated/not fully vaccinated/do not know if they are immune/decided to be vaccinated after joining KCH; and what measures or interventions may help healthcare workers when deciding whether to get the MMR vaccine.
Trial arms
Trial start
2024-07-01
Estimated PCD
2024-10-01
Trial end
2025-02-01
Status
Not yet recruiting
Treatment
MMR vaccination
MMR vaccination status
Arms:
Healthcare workers
Size
30
Primary endpoint
Barriers to MMR vaccination
Collected at one timepoint 1 day during qualitative interview
Facilitators to MMR vaccination
Collected at one timepoint 1 day during qualitative interview
Reasons for not knowing immunity status
Collected at one timepoint 1 day during qualitative interview
Eligibility criteria
Inclusion Criteria: * Are aged 18 and over * Currently work as a healthcare worker at KCH * Have direct contact with patients * Don't know if they have had measles and don't know if they have been vaccinated * Or: Have not had measles and have not received the MMR vaccine * Or: Have only received 1 dose of the MMR vaccine * Or: Received the MMR vaccine after joining KCH Exclusion Criteria: * Are aged \<18 years old * Work in a role at KCH that does not involve direct contact with patients (e.g., administrative or business staff) * Have had measles in the past or both doses of the MMR vaccine before joining KCH * Are not able to give informed consent
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_ONLY', 'timePerspective': 'CROSS_SECTIONAL'}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2024-06-13

1 organization

1 product

1 indication

Indication
Measles